GAM Holding’s Supernus Pharmaceuticals SUPN Stock Holding History

GAM Holding’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,684	Closed	-$236K	–	880
2018 Q3	$236K	Buy	+4,684	New	+$231K	0.01%	827

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

GAM Holding's SUPN Position: Q4 2018 in Review

GAM Holding sold out of Supernus Pharmaceuticals (SUPN) in Q4 2018, closing a stake of 4,684 shares — an estimated $236K sold.

GAM Holding first reported a position in SUPN in Q3 2018 and held it in 1 quarter. The position peaked at $236K in Q3 2018. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

GAM Holding reported no remaining Supernus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
GAM Holding sold 4,684 Supernus Pharmaceuticals shares in Q4 2018, an estimated $236K.
GAM Holding first reported a position in Supernus Pharmaceuticals in Q3 2018 and held it in 1 quarter.
GAM Holding's Supernus Pharmaceuticals position peaked at $236K in Q3 2018.
274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on GAM Holding's 13F filing for Q4 2018, filed 8 Feb 2019.